Free Trial

SNDL (NASDAQ:SNDL) Rating Lowered to "Strong Sell" at Zacks Research

SNDL logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks downgraded SNDL from a "hold" to a "strong sell," while Weiss Ratings reaffirmed a "sell (D-)" and the consensus analyst rating is Reduce with an average price target of $5.00.
  • SNDL reported an EPS beat ($0.03 vs. $0.01) but missed revenue estimates badly (reported $183.87M vs. $257.97M expected), prompting negative investor sentiment and management to announce cost cuts and margin-focused initiatives.
  • Shares trade around $1.36 with a market cap near $350M and display weak profitability metrics (negative net margin and negative ROE), and analysts forecast a -$0.04 EPS for the current fiscal year.
  • Five stocks we like better than SNDL.

SNDL (NASDAQ:SNDL - Get Free Report) was downgraded by Zacks Research from a "hold" rating to a "strong sell" rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Separately, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of SNDL in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Reduce" and an average price target of $5.00.

Get Our Latest Research Report on SNDL

SNDL Stock Up 3.4%

SNDL stock opened at $1.36 on Wednesday. The company has a quick ratio of 3.47, a current ratio of 4.88 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $350.06 million, a PE ratio of -45.33 and a beta of 0.81. SNDL has a twelve month low of $1.15 and a twelve month high of $2.89. The stock has a 50-day simple moving average of $1.45 and a two-hundred day simple moving average of $1.67.

SNDL (NASDAQ:SNDL - Get Free Report) last posted its earnings results on Thursday, March 12th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.02. SNDL had a negative return on equity of 1.02% and a negative net margin of 1.19%.The business had revenue of $183.87 million during the quarter, compared to analyst estimates of $257.97 million. On average, equities analysts predict that SNDL will post -0.04 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Traynor Capital Management Inc. purchased a new position in shares of SNDL during the third quarter worth about $27,000. Private Advisor Group LLC purchased a new position in shares of SNDL during the first quarter worth about $28,000. Hilton Capital Management LLC purchased a new position in shares of SNDL during the second quarter worth about $30,000. PFG Investments LLC grew its holdings in shares of SNDL by 53.8% during the fourth quarter. PFG Investments LLC now owns 20,000 shares of the company's stock worth $33,000 after purchasing an additional 7,000 shares in the last quarter. Finally, FSM Wealth Advisors LLC purchased a new position in shares of SNDL during the fourth quarter worth about $33,000.

Trending Headlines about SNDL

Here are the key news stories impacting SNDL this week:

About SNDL

(Get Free Report)

SNDL Inc, formerly known as Sundial Growers Inc, is a Canada-based consumer packaged goods company focused on the production, manufacturing and distribution of cannabis products. Headquartered in Calgary, Alberta, SNDL operates multiple cultivation and processing facilities across Canada, including indoor and hybrid greenhouses in British Columbia and Ontario. The company serves both adult-use and medical cannabis markets, supplying provincial distributors as well as operating through its own wholesale and retail networks.

The company's product portfolio spans dried flower, pre-rolls, vape cartridges, cannabis oils, edibles and infused beverages under a variety of in-house brands.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SNDL Right Now?

Before you consider SNDL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SNDL wasn't on the list.

While SNDL currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines